[1]温少瑾,杨焕莹,孙凤歧,等.NF-κB信号通路与多发性骨髓瘤发病机制的相关性及靶向治疗作用的研究进展[J].西部中医药,2024,37(07):97-102.[doi:10.12174/j.issn.2096-9600.2024.07.23]
　WEN Shaojin,YANG Huanying,SUN Fengqi,et al.Research Progress in the Correlation between NF-κB Signaling Pathway and the Pathogenesis of Multiple Myeloma， and the Targeted Therapeutic Effects[J].Western Journal of Traditional Chinese Medicine,2024,37(07):97-102.[doi:10.12174/j.issn.2096-9600.2024.07.23]
点击复制

NF-κB信号通路与多发性骨髓瘤发病机制的相关性及靶向治疗作用的研究进展
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年07期
页码:
97-102
栏目:
研究进展
出版日期:
2024-07-15

文章信息/Info

Title:
Research Progress in the Correlation between NF-κB Signaling Pathway and the Pathogenesis of Multiple Myeloma， and the Targeted Therapeutic Effects
作者:
温少瑾1, 杨焕莹2, 孙凤歧1, 申小惠1
1.甘肃省中医院，甘肃 兰州 730050
2.天津市河东区中医医院，天津 300162
Author(s):
WEN Shaojin1, YANG Huanying2, SUN Fengqi1, SHEN Xiaohui1
1.Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China
2.Tianjin Hedong District Hospital of Traditional Chinese Medicine, Tianjin 300162, China
关键词:
多发性骨髓瘤; NF-B信号通路; 靶向治疗
Keywords:
multiple myeloma; NF-B signaling pathway; targeted therapy
分类号:
R738.1
DOI:
10.12174/j.issn.2096-9600.2024.07.23
文献标志码:
A
摘要:
通过对核因子kappa B信号通路进行阐述，分析其与多发性骨髓瘤（multiple myeloma，MM）发病机制的关系，及对其靶向治疗的相关研究进行综述，分析其现存的问题和未来发展的方向，以期为MM的靶向治疗提供新思路。
Abstract:
By illustrating the NF-κB signalling pathway, we analysed its correlation with the pathogenesis of multiple myeloma (MM), summarized the studies related to its targeted therapy, and explored the existing problems and the future development direction, so as to provide new thinking for the targeted therapy of MM.

相似文献/References:

[1]夏弋钦,修丽梅,郭利华.中药单体及复方对肝癌细胞中NF-κB相关信号通路的作用机制[J].西部中医药,2021,34(01):125.[doi:10.12174/j.issn.2096-9600.2021.01.33]
　XIA Yiqing,XIU Limei,GUO Lihua.The Mechanism of TCM Monomer and Compound in Inhibiting the Proliferation of Hepatoma Cells Through NF-κB Related Signaling Pathway[J].Western Journal of Traditional Chinese Medicine,2021,34(07):125.[doi:10.12174/j.issn.2096-9600.2021.01.33]
[2]许敏,曾清,程纬民,等.毒结清口服液联合VAD方案治疗多发性骨髓瘤疗效观察[J].西部中医药,2024,37(03):147.[doi:10.12174/j.issn.2096-9600.2024.03.30]
　XU Min,ZENG Qing,CHENG Weimin,et al.Clinical Observation on Dujieqing Oral Liquid and VAD Regimen in the Treatment of Multiple Myeloma[J].Western Journal of Traditional Chinese Medicine,2024,37(07):147.[doi:10.12174/j.issn.2096-9600.2024.03.30]

备注/Memo

备注/Memo:
温少瑾（1984—），女，硕士学位，主治医师。研究方向：肿瘤与血液病的研究。E-mail：wenshaojin@163.com。甘肃省自然科学基金（22JR5RA623）。
更新日期/Last Update: 2024-07-15